-
Fund Dashboard
- Holdings
PGIM Jennison Health Sciences Fund
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
LLY Eli Lilly and Company | 219.30 mm | 275.73 k shares | 12.44 | Common equity | Long | USA |
UNH UnitedHealth Group Incorporated | 99.06 mm | 162.33 k shares | 5.62 | Common equity | Long | USA |
BMY Bristol-Myers Squibb Company | 80.36 mm | 1.36 mm shares | 4.56 | Common equity | Long | USA |
ARGX argenx SE | 79.19 mm | 128.44 k shares | 4.49 | Common equity | Long | Netherlands |
BSX Boston Scientific Corporation | 73.69 mm | 812.82 k shares | 4.18 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals Incorporated | 70.32 mm | 150.22 k shares | 3.99 | Common equity | Long | USA |
NVO Novo Nordisk A/S | 70.00 mm | 655.47 k shares | 3.97 | Common equity | Long | Denmark |
AMGN Amgen Inc. | 69.29 mm | 244.95 k shares | 3.93 | Common equity | Long | USA |
AZN AstraZeneca PLC | 57.75 mm | 854.04 k shares | 3.27 | Common equity | Long | UK |
ISRG Intuitive Surgical, Inc. | 57.66 mm | 106.38 k shares | 3.27 | Common equity | Long | USA |
(PIPA070) PGIM Core Government Money Market Fund | 56.83 mm | 56.83 mm shares | 3.22 | Short-term investment vehicle | Long | USA |
CRNX Crinetics Pharmaceuticals, Inc. | 51.96 mm | 908.39 k shares | 2.95 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 48.91 mm | 528.31 k shares | 2.77 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 39.30 mm | 310.07 k shares | 2.23 | Common equity | Long | USA |
Cigna Holding Co | 38.77 mm | 114.77 k shares | 2.20 | Common equity | Long | USA |
PCVX Vaxcyte, Inc. | 36.69 mm | 388.88 k shares | 2.08 | Common equity | Long | USA |
PGIM Institutional Money Market Fund - D | 36.17 mm | 36.20 mm shares | 2.05 | Short-term investment vehicle | Long | USA |
CVS CVS Health Corporation | 36.13 mm | 603.62 k shares | 2.05 | Common equity | Long | USA |
UCB United Community Banks, Inc. | 35.81 mm | 182.61 k shares | 2.03 | Common equity | Long | Belgium |
ARQT Arcutis Biotherapeutics, Inc. | 35.66 mm | 2.74 mm shares | 2.02 | Common equity | Long | USA |
EW Edwards Lifesciences Corporation | 34.76 mm | 487.17 k shares | 1.97 | Common equity | Long | USA |
APLS Apellis Pharmaceuticals, Inc. | 33.83 mm | 997.11 k shares | 1.92 | Common equity | Long | USA |
VRNA Verona Pharma plc | 33.37 mm | 842.08 k shares | 1.89 | Common equity | Long | UK |
INSM Insmed Incorporated | 30.20 mm | 401.81 k shares | 1.71 | Common equity | Long | USA |
QGEN Qiagen N.V. | 30.03 mm | 691.39 k shares | 1.70 | Common equity | Long | Netherlands |
NARI Inari Medical, Inc. | 26.25 mm | 505.62 k shares | 1.49 | Common equity | Long | USA |
VERA Vera Therapeutics, Inc. | 20.33 mm | 408.64 k shares | 1.15 | Common equity | Long | USA |
TARS Tarsus Pharmaceuticals, Inc. | 20.08 mm | 382.77 k shares | 1.14 | Common equity | Long | USA |
DXCM DexCom, Inc. | 19.42 mm | 249.03 k shares | 1.10 | Common equity | Long | USA |
DYN Dyne Therapeutics, Inc. | 18.82 mm | 614.99 k shares | 1.07 | Common equity | Long | USA |
COO The Cooper Companies, Inc. | 18.81 mm | 180.07 k shares | 1.07 | Common equity | Long | USA |
A Agilent Technologies, Inc. | 18.47 mm | 133.84 k shares | 1.05 | Common equity | Long | USA |
LBPH Longboard Pharmaceuticals, Inc. | 17.40 mm | 290.17 k shares | 0.99 | Common equity | Long | USA |
KYMR Kymera Therapeutics, Inc. | 16.96 mm | 362.03 k shares | 0.96 | Common equity | Long | USA |
XENE Xenon Pharmaceuticals Inc. | 16.00 mm | 375.32 k shares | 0.91 | Common equity | Long | Canada |
ALNY Alnylam Pharmaceuticals, Inc. | 15.86 mm | 62.66 k shares | 0.90 | Common equity | Long | USA |
PHAT Phathom Pharmaceuticals, Inc. | 15.80 mm | 1.78 mm shares | 0.90 | Common equity | Long | USA |
KRYS Krystal Biotech, Inc. | 14.69 mm | 74.41 k shares | 0.83 | Common equity | Long | USA |
Lonza Group AG
|
13.18 mm | 21.98 k shares | 0.75 | Common equity | Long | Switzerland |
TNDM Tandem Diabetes Care, Inc. | 13.05 mm | 426.14 k shares | 0.74 | Common equity | Long | USA |
BPMC Blueprint Medicines Corporation | 13.04 mm | 135.28 k shares | 0.74 | Common equity | Long | USA |
IDYA IDEAYA Biosciences, Inc. | 12.94 mm | 472.84 k shares | 0.73 | Common equity | Long | USA |
NAMS NewAmsterdam Pharma Company N.V. | 9.71 mm | 489.13 k shares | 0.55 | Common equity | Long | Netherlands |
MRVI Maravai LifeSciences Holdings, Inc. | 9.63 mm | 1.70 mm shares | 0.55 | Common equity | Long | USA |
TRML Tourmaline Bio, Inc. | 9.05 mm | 347.50 k shares | 0.51 | Common equity | Long | USA |
ALGN Align Technology, Inc. | 8.75 mm | 37.59 k shares | 0.50 | Common equity | Long | USA |
STVN Stevanato Group S.p.A. | 7.98 mm | 398.19 k shares | 0.45 | Common equity | Long | Italy |
TVTX Travere Therapeutics, Inc. | 7.40 mm | 393.26 k shares | 0.42 | Common equity | Long | USA |
MLYS Mineralys Therapeutics, Inc. | 6.72 mm | 526.32 k shares | 0.38 | Common equity | Long | USA |
CABA Cabaletta Bio, Inc. | 5.27 mm | 1.38 mm shares | 0.30 | Common equity | Long | USA |
APGE Apogee Therapeutics, Inc. | 5.08 mm | 112.50 k shares | 0.29 | Common equity | Long | USA |
ANAB AnaptysBio, Inc. | 2.74 mm | 109.71 k shares | 0.16 | Common equity | Long | USA |